Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AlloVir Inc.

www.allovir.com

Latest From AlloVir Inc.

Tech Transfer Roundup: Universities And Biotechs Continue To Look For Ways To Combat COVID-19

AlloVir/Baylor, Soligenix/Hawaii and CEL-SCI/Georgia ink coronavirus collaborations, but deal-making continues in other areas as well, including Asklepios/UNC teaming on a gene therapy for Angelman syndrome and DeMelle licensing a targeted pancreatic cancer drug from Moffitt, among others.

Deals Coronavirus COVID-19

AlloVir Gains PRIME Status For Anti-Virus T-Cell Therapy

Joining the ElevateBio stable last May, the company has now gained priority status in the US and Europe for its novel therapy for viral infections in stem cell transplant patients.

Infectious Diseases Europe

Novel Ticagrelor Reversal Agent Wins Place On EMA’s PRIME

Only two of seven recent applications for entry into the European Medicines Agency’s priority medicines scheme for getting treatments for unmet medical needs to patients faster made the grade.

Europe Regulation

Giroir Becomes Acting US FDA Commissioner, Giving Agency Experienced Political Hand

Assistant HHS secretary for health has led policy development for several offices since his 2018 confirmation and also has industry and clinical experience.

FDA Leadership
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • ViraCyte LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • AlloVir Inc.
  • Senior Management
  • David Hallal, Chmn. & CEO
    Vikas Sinha, Pres. & CFO
    Augustin Melian, PhD, CMO
    Ann M Leen, PhD, CSO
  • Contact Info
  • AlloVir Inc.
    Phone: (651) 628-9259
    2925 Richmond Ave., Ste. 1200
    Houston, TX 77098
    USA
UsernamePublicRestriction

Register